Premium
Prophylaxis of Pneumocystis carinii pneumonia in patients with HIV infection
Author(s) -
Coker Richard J,
Mitchell David M
Publication year - 1993
Publication title -
journal of the european academy of dermatology and venereology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.655
H-Index - 107
eISSN - 1468-3083
pISSN - 0926-9959
DOI - 10.1111/j.1468-3083.1993.tb00024.x
Subject(s) - pneumocystis carinii , medicine , immunosuppression , pneumonia , incidence (geometry) , human immunodeficiency virus (hiv) , immunology , opportunistic infection , complication , pneumocystis pneumonia , intensive care medicine , viral disease , pneumocystis jirovecii , physics , optics
Pneumocystis carinii pneumonia (PCP) is a frequent complication of immunosuppression secondary to infection by the human immunodeficiency virus (HIV). The use of primary and secondary prophylaxis for many of the opportunist infections associated with acquired immunodeficiency syndrome (AIDS) have reduced their incidence and prophylaxis for PCP is no exception. There are, however, still problems associated with the different regimens currently widely used. The efficacy, toxicity and cost of prophylaxis agents are considered.